Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Automated basal insulin delivery versus multiple daily injections in type 1 diabetes: results from a randomized parallel controlled trial.
Journal: Frontiers in endocrinology
Published: September 30, 2025
Accuracy of the 15.5-Day G7 iCGM in Adults with Diabetes.
Journal: Diabetes technology & therapeutics
Published: March 20, 2025
Glycemic Outcomes During Early Use of the MiniMed™ 780G Advanced Hybrid Closed-Loop System with Guardian™ 4 Sensor.
Journal: Diabetes technology & therapeutics
Published: May 30, 2023
Publisher Correction: Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial.
Journal: Nature medicine
Published: March 18, 2023
Improved Glycemia with Hybrid Closed-Loop Versus Continuous Subcutaneous Insulin Infusion Therapy: Results from a Randomized Controlled Trial.
Journal: Diabetes technology & therapeutics
Published: December 06, 2022
Reduction in Postprandial Peak Glucose With Increased Technosphere Insulin Dosage.
Journal: Journal of diabetes science and technology
Published: July 14, 2022
Accuracy of a Seventh-Generation Continuous Glucose Monitoring System in Children and Adolescents With Type 1 Diabetes.
Journal: Journal of diabetes science and technology
Published: April 25, 2022
Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with Diabetes.
Journal: Diabetes technology & therapeutics
Published: February 14, 2022
Efficacy, safety, tolerability, and noninferiority phase 3 study of glucagon as a ready-to-use room temperature liquid stable formulation versus a lyophilised formulation for the biochemical recovery and symptomatic relief of insulin-induced severe hypoglycaemia in adults with type 1 diabetes.
Journal: Diabetes, obesity & metabolism
Published: January 10, 2022
Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes.
Journal: Diabetes technology & therapeutics
Published: October 25, 2021
Evaluation of Accuracy and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE Study.
Journal: Diabetes technology & therapeutics
Published: September 13, 2021
Last Updated: 09/26/2026